Current Pharmaceutical Design
Title: Editorial [Drugs Promoting Wakefulness and Performance Executive Editor: J.G. Ramaekers]
Volume: 12 Issue: 20
Author(s): J. G. Ramaekers
Affiliation:
Export Options
About this article
Cite this article as:
Ramaekers G. J., Editorial [Drugs Promoting Wakefulness and Performance Executive Editor: J.G. Ramaekers], Current Pharmaceutical Design 2006; 12 (20) . https://dx.doi.org/10.2174/138161206777698846
DOI https://dx.doi.org/10.2174/138161206777698846 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
8
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric Oxide and Dietary Factors: Part V Summary/Conclusion and References
Vascular Disease Prevention (Discontinued) Deep Learning for Alzheimer’s Disease Classification using Texture Features
Current Medical Imaging Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Diversity-Oriented Synthetic Approaches for Furoindoline: A Review
Current Organic Synthesis An Overview of Drug Screening Using Primary and Embryonic Stem Cells
Combinatorial Chemistry & High Throughput Screening Heat Shock Proteins And Neuroprotection
Recent Patents on DNA & Gene Sequences 5-Hydroxytryptamine (5-HT) Receptor Ligands
Current Pharmaceutical Design Cardiovascular effect of Nigella sativa L. Aqueous Extract in Normal Rats
Cardiovascular & Hematological Disorders-Drug Targets Genetic Approaches for Antigen-Selective Cell Therapy
Current Gene Therapy Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets Radiolabelled Regulatory Peptides for Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia
Current Neurovascular Research Hormonal Contraception and the Brain: Examining Cognition and Psychiatric Disorders
Current Psychiatry Research and Reviews Intrinsically Fluorescent Base-Discriminating Nucleoside Analogs
Mini-Reviews in Organic Chemistry Mitochondria: the Headquarters in Ischemia-Induced Neuronal Death
Central Nervous System Agents in Medicinal Chemistry Modulation of the FGF14:FGF14 Homodimer Interaction Through Short Peptide Fragments
CNS & Neurological Disorders - Drug Targets Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice
CNS & Neurological Disorders - Drug Targets Validity of Alcohol Screening Instruments in General Population Gender Studies: An Analytical Review
Current Drug Abuse Reviews The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
Current Pharmaceutical Design Editorial [Hot Topic: Recent Advances in Stroke: Molecular Mechanisms, Approaches, and Treatments (Guest Editor: Xin Wang)]
Central Nervous System Agents in Medicinal Chemistry